Effective Treatment of Pediatric Craniopharyngioma through Bleomycin Chemotherapy

Japanese researchers reported the efficacy of postoperative intratumoral chemotherapy with bleomycin for craniopharyngiomas in a 1985 study. However, the treatment had not been widely implemented until a long-term outcome and reconsideration of the treatment were conducted. H. Takahashi and colleagues from Nippon Medical School investigated the effectiveness of local bleomycin chemotherapy in treating 11 pediatric patients with recurrent cystic craniopharyngioma. The study, published in Childs Nervous System in 2005, showed promising results, with 7 out of 11 children experiencing almost complete disappearance of cystic recurrences and achieving a good school life.

Key Takeaways:

• 7 children were treated with intracystic injection of bleomycin in 1985, with 1 patient experiencing fair clinical outcome and 6 showing excellent outcomes.
• 11 children were treated with intracystic injection of bleomycin between 1988 and 2004, with 7 experiencing almost complete disappearance of cystic recurrences.
• Recurrence was observed in 3 children after additional stereotactic radiosurgery, but the treatment was eventually successful.
• The researchers concluded that local bleomycin chemotherapy is effective and recurrence does not occur after follow-up, which ranged in duration from 3 to 16 years.
• H. Takahashi and colleagues reported their study in Childs Nervous System, highlighting the potential of bleomycin chemotherapy in treating pediatric craniopharyngioma.
• The study's findings suggest that intracystic injection of bleomycin may be a viable treatment option for patients with recurrent cystic craniopharyngioma.

Statistics:

• 7 children were initially treated with intracystic injection of bleomycin in 1985.
• 11 children were treated between 1988 and 2004, with a total of 18 patients receiving the treatment.
• 7 out of 11 children experienced almost complete disappearance of cystic recurrences.
• Follow-up periods ranged from 3 to 16 years, with a median of 10 years.
• The study demonstrated a high success rate of 70% in terms of cystic recurrence disappearance.

Sources:

• Childs Nerv Syst, 2005;21(8-9):701-704
• Health & Medicine Week
• NewsRx.com
• Takahashi H, et al. (2005). Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Childs Nerv Syst, 21(8-9), 701-704.